Skip to contentI
Integra Lifesciences Holdings Corp
I
IARTIntegra Lifesciences Holdings Corp Q3 2015 · 10-Q
Revenue$226.37M$226.37M+14.6% vs Q3 2014 Net Income-$31.88M-$31.88MN/M vs Q3 2014 EPS Diluted-$0.45-$0.45N/M vs Q3 2014 Gross Profit$140,298,000+13.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR
Operating Cash Flowderived$19,611,000−36.9% Free Cash Flowderived$14,250,000−42.2% Margins · derivedGross margin62.0%−0.6 pt vs Q3 2014
Operating margin4.4%−4.2 pt vs Q3 2014
Net margin-14.1%−19.0 pt vs Q3 2014
ended Sep 30, 2015 · filed Nov 4, 2015 · 35 d after period end